# AGREEMENT REFERENCE: AGR-QUA-202404-235  

## STRATEGIC PARTNERSHIP AND SERVICES AGREEMENT  

This STRATEGIC PARTNERSHIP AND SERVICES AGREEMENT (this “**Agreement**”), reference number **AGR-QUA-202404-235**, is made and entered into as of **April 14, 2024** (the “**Effective Date**”), by and between:

- **Contoso Enterprises**, a [jurisdiction of organization] corporation, with its principal place of business at [Contoso Address] (hereinafter referred to as “**Contoso**”, the “**Client**” or the “**Company**”); and  

- **Quantum Labs**, a [jurisdiction of organization] corporation, with its principal place of business at [Quantum Labs Address] (hereinafter referred to as “**Quantum Labs**”, the “**Vendor**” or the “**Service Provider**”).  

Contoso and Quantum Labs are sometimes referred to herein individually as a “**Party**” and collectively as the “**Parties**.”

---

## RECITALS  

WHEREAS, Contoso desires to engage Quantum Labs to provide certain technology development, integration, analytics, and related professional services, including but not limited to the design, development, implementation, and support of advanced data analytics and machine-learning–enabled solutions for Contoso’s internal business operations and its customers (collectively, the “Services” as defined below);  

WHEREAS, Quantum Labs is in the business of providing advanced technology solutions, including software development, systems integration, data analytics, artificial intelligence and machine-learning services, consulting, support, and related professional services, and has the expertise, resources, and personnel to perform the Services;  

WHEREAS, the Parties desire to establish a strategic partnership under which Quantum Labs will provide the Services and Deliverables on the terms and conditions set forth in this Agreement, and Contoso will compensate Quantum Labs in accordance with the fee structure, milestones, and other commercial arrangements described herein;  

WHEREAS, the Parties wish to define their respective rights, responsibilities, and obligations, including with respect to confidentiality, data protection, intellectual property rights, service levels, and risk allocation, and to set forth the terms and conditions governing the Services for the duration of the Agreement;  

NOW, THEREFORE, in consideration of the mutual covenants, promises, and undertakings set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

---

## ARTICLE I – DEFINITIONS  

1.1 **“Affiliate”** means, with respect to a Party, any entity that directly or indirectly controls, is controlled by, or is under common control with such Party, where “control” means ownership of more than fifty percent (50%) of the voting interests of such entity or the ability to direct its management.  

1.2 **“Agreement”** means this Strategic Partnership and Services Agreement, reference number **AGR-QUA-202404-235**, together with all Schedules, Exhibits, Statements of Work, and written amendments hereto.  

1.3 **“Applicable Law”** means any and all federal, state, local, foreign or international laws, statutes, ordinances, rules, regulations, orders, judgments, decrees, or other requirements of any governmental authority that are applicable to a Party, the Services, or this Agreement, including, as applicable, the General Data Protection Regulation (EU) 2016/679 (“GDPR”) and the California Consumer Privacy Act of 2018, as amended (“CCPA”).  

1.4 **“Business Day”** means any day other than a Saturday, Sunday, or public holiday on which banks are generally open for business in New York, New York, U.S.A.  

1.5 **“Client Data”** means all data, information, records, content, and materials, including personal data, provided or made available by or on behalf of Contoso or its Affiliates, customers, or end users to Quantum Labs in connection with this Agreement, or otherwise accessed or processed by Quantum Labs in the course of performing the Services.  

1.6 **“Confidential Information”** has the meaning set forth in Section 5.1.  

1.7 **“Deliverables”** means all reports, software, documentation, models, analyses, designs, configurations, specifications, and other work product, in any form or medium, that are to be delivered by Quantum Labs to Contoso under this Agreement or any Statement of Work, including any interim, partial, or draft deliverables.  

1.8 **“Documentation”** means any and all user manuals, technical manuals, operating instructions, training materials, specifications, and other written or electronic materials describing the functionality, features, and operation of the Deliverables or Services.  

1.9 **“Fees”** means all fees, charges, and other amounts payable by Contoso to Quantum Labs under this Agreement, including but not limited to the contract value and any additional fees for change requests, out-of-scope work, or reimbursable expenses, as set forth in Article III and in any Statement of Work.  

1.10 **“Force Majeure Event”** has the meaning set forth in Section 15.1.  

1.11 **“Intellectual Property Rights”** or **“IPR”** means all patents, patent applications, trademarks, service marks, trade names, logos, copyrights, trade secrets, moral rights, design rights, database rights, know-how, and all other intellectual property rights, whether registered or unregistered, and all applications, renewals, extensions, and restorations thereof, in any jurisdiction.  

1.12 **“Personal Data”** means any information relating to an identified or identifiable natural person, or any similar term as defined under Applicable Law (including “personal information” under CCPA), which is processed by Quantum Labs on behalf of Contoso in connection with this Agreement.  

1.13 **“Service Levels”** means the performance and availability standards and metrics described in Article XII (Service Level Agreements) and any applicable Statement of Work.  

1.14 **“Services”** means the services to be provided by Quantum Labs under this Agreement, including without limitation consulting, design, development, configuration, integration, testing, deployment, support, maintenance, training, and related professional services, as more particularly described in Article II and any Statement of Work.  

1.15 **“Specifications”** means the written functional, technical, and performance specifications for the Services and Deliverables set forth in this Agreement, including any Statement of Work or change order agreed upon by the Parties.  

1.16 **“Statement of Work”** or **“SOW”** means any written statement of work, work order, or similar document entered into by the Parties that references this Agreement and describes particular Services, Deliverables, milestones, timelines, and Fees.  

1.17 **“Term”** means the period from the Effective Date until the Expiration Date, unless earlier terminated in accordance with Article IV.  

1.18 **“Third-Party Materials”** means any software, tools, libraries, data sets, or other materials that are owned by third parties and used by Quantum Labs in the performance of the Services or incorporated into the Deliverables.  

1.19 **“Work Product”** means all Deliverables and any other materials, inventions, developments, works of authorship, data, and other results created, conceived, or reduced to practice by Quantum Labs (alone or jointly with others) in the course of performing the Services, excluding Vendor Pre-Existing IP (as defined in Section 6.3).  

---

## ARTICLE II – SCOPE OF SERVICES / WORK  

2.1 **General Description of Services.**  
Quantum Labs shall provide to Contoso the Services described in this Article II and in one or more SOWs. The Services shall include, without limitation:  

  2.1.1 the design and development of advanced data analytics and machine-learning solutions tailored to Contoso’s business needs;  

  2.1.2 the integration of such solutions with Contoso’s existing systems, applications, and data sources;  

  2.1.3 the configuration, customization, and optimization of software modules, models, and workflows;  

  2.1.4 the provision of ongoing technical support, maintenance, and monitoring in accordance with Article XII; and  

  2.1.5 the provision of training, documentation, and knowledge transfer to Contoso’s personnel.  

2.2 **Deliverables.**  
Without limiting the generality of Section 2.1, Quantum Labs shall provide the following categories of Deliverables (subject to further detail in applicable SOWs):  

  (a) **Solution Architecture Documentation.** A detailed high-level and low-level architecture for the analytics and machine-learning solution, including system diagrams, data flow diagrams, and integration points with Contoso’s existing systems.  

  (b) **Configured Analytics Platform.** A configured environment (cloud-based, on-premise, or hybrid, as specified in the applicable SOW) that includes data ingestion pipelines, data transformation scripts, model training pipelines, and dashboards.  

  (c) **Trained Machine-Learning Models.** One or more trained models for use cases identified by Contoso (for example, forecasting, anomaly detection, or customer segmentation), with documented training data sources, performance metrics, and hyperparameters.  

  (d) **Dashboards and Reports.** Custom dashboards and reporting templates designed to provide Contoso with operational and strategic insights, including defined KPIs, metrics, and visualizations.  

  (e) **Integration Components.** APIs, connectors, and ETL jobs required to exchange data between the analytics platform and Contoso’s CRM, ERP, or other systems.  

  (f) **Testing and Validation Artifacts.** Test plans, test cases, test results, and validation reports documenting performance against the Specifications.  

  (g) **Operational Documentation and Training Materials.** User guides, administration manuals, and training curricula for Contoso’s end users and administrators.  

2.3 **Project Phases and Timelines.**  
The overall project will be structured into phases, which may include (by way of example):  

  2.3.1 **Discovery and Requirements Phase** (estimated 4–6 weeks). During this phase, Quantum Labs shall work with Contoso to gather business requirements, define use cases, and identify data sources. Deliverables shall include a requirements specification and a high-level solution design.  

  2.3.2 **Design and Architecture Phase** (estimated 4–8 weeks). Quantum Labs shall produce detailed solution architecture, data models, and integration designs. The Parties shall agree in writing to the Specifications for the Deliverables before development commences.  

  2.3.3 **Development and Configuration Phase** (estimated 12–16 weeks). Quantum Labs shall implement the approved design, configure the analytics platform, develop data pipelines, train models, and build dashboards and integrations. Intermediate milestones and partial Deliverables shall be provided at agreed intervals.  

  2.3.4 **Testing and User Acceptance Phase** (estimated 4–6 weeks). Quantum Labs shall conduct system testing and support Contoso during user acceptance testing (“UAT”). Quantum Labs shall remedy any material defects identified during UAT in accordance with Article XII and Section 7.4.  

  2.3.5 **Deployment and Go-Live Phase** (estimated 2–4 weeks). Quantum Labs shall assist with production deployment, data migration (if applicable), and final cutover.  

  2.3.6 **Support and Optimization Phase** (through the remainder of the Term). Quantum Labs shall provide ongoing support, maintenance, and optimization services, including performance tuning, model retraining, and minor enhancements, as specified in Article XII and the applicable SOW.  

The specific timelines, milestones, and acceptance criteria for each phase shall be set forth in one or more SOWs. In the event of any conflict between this Article II and an SOW, the SOW shall govern as to the specific Services described therein, except where explicitly stated otherwise.  

2.4 **Performance Standards.**  
Quantum Labs shall perform the Services:  

  (a) in a professional and workmanlike manner, in accordance with generally accepted industry standards and practices;  

  (b) in compliance with the Specifications and Service Levels;  

  (c) using personnel with appropriate skills, training, and experience; and  

  (d) in compliance with Applicable Law, including data protection and privacy laws referenced in Article XI.  

2.5 **Client Responsibilities.**  
Contoso acknowledges that Quantum Labs’ ability to perform the Services depends upon Contoso’s timely performance of its obligations. Without limiting the foregoing, Contoso shall:  

  (a) provide timely access to relevant personnel, systems, documentation, and facilities, as reasonably requested by Quantum Labs;  

  (b) provide accurate and complete information and Client Data necessary for Quantum Labs to perform the Services;  

  (c) designate a primary point of contact and project manager to coordinate with Quantum Labs;  

  (d) perform any tasks and responsibilities assigned to Contoso in this Agreement or in any SOW; and  

  (e) review and provide feedback or approvals on Deliverables and milestones within the timeframes specified in the applicable SOW.  

2.6 **Acceptance of Deliverables.**  

  2.6.1 **Review Period.** Upon delivery of a Deliverable, Contoso shall have the review period set forth in the applicable SOW (and if none is specified, fifteen (15) Business Days) to review and either: (i) accept the Deliverable in writing; or (ii) reject the Deliverable by providing Quantum Labs with a written notice reasonably describing any material non-conformities with the Specifications.  

  2.6.2 **Remedy of Non-Conformities.** If Contoso timely rejects a Deliverable, Quantum Labs shall, at no additional cost to Contoso, promptly correct the non-conformities and re-deliver the Deliverable for further review and acceptance in accordance with Section 2.6.1.  

  2.6.3 **Deemed Acceptance.** If Contoso does not provide a written acceptance or rejection within the applicable review period, the Deliverable shall be deemed accepted as of the last day of such review period.  

2.7 **Subcontracting.**  
Quantum Labs may use subcontractors to perform portions of the Services, provided that: (a) Quantum Labs remains fully responsible for the acts and omissions of its subcontractors; (b) any subcontractor with access to Client Data or Confidential Information is bound by confidentiality and data protection obligations no less stringent than those in this Agreement; and (c) Quantum Labs shall not subcontract outside of the jurisdictions materially impacting data residency requirements expressed in writing by Contoso, without Contoso’s prior written consent.  

---

## ARTICLE III – FEES AND PAYMENT TERMS  

3.1 **Contract Value.**  
The total contract value for the initial scope of Services under this Agreement is **Three Million Five Hundred Seventy-One Thousand One Hundred Sixteen U.S. Dollars (US$3,571,116)** (the “**Contract Value**”), subject to adjustments for approved change orders in accordance with Article XIII.  

3.2 **Fee Structure.**  
Unless otherwise specified in an SOW, the Fees shall be structured as follows:  

  (a) **Fixed-Fee Components.** Certain phases or Deliverables (such as the Discovery and Design phases) may be priced on a fixed-fee basis, as set forth in the applicable SOW.  

  (b) **Milestone-Based Payments.** Development, integration, and deployment phases shall be tied to milestones. Each milestone shall have an associated payment amount and acceptance criteria specified in the SOW.  

  (c) **Time-and-Materials Components.** Ongoing support, optimization, and additional consulting services beyond the agreed scope may be billed on a time-and-materials basis at the hourly or daily rates set forth in the applicable SOW or rate card agreed to in writing between the Parties.  

3.3 **Payment Milestones.**  
By way of example, an SOW may allocate the Contract Value as follows (actual allocation to be finalized in the SOW):  

  - 15% upon execution of this Agreement and any initial SOW (kickoff and mobilization);  
  - 20% upon acceptance of the detailed design and architecture Deliverables;  
  - 30% upon completion of development and delivery of key functional modules;  
  - 20% upon successful completion of user acceptance testing;  
  - 10% upon production go-live; and  
  - 5% pro-rated for post-go-live support and optimization over the remaining Term.  

3.4 **Invoicing and Payment Terms.**  

  3.4.1 **Invoicing.** Quantum Labs shall invoice Contoso upon achievement of the applicable milestone or on a monthly basis for time-and-materials work, as specified in the SOW. Each invoice shall reference the Agreement (including reference number AGR-QUA-202404-235), the applicable SOW, and the milestone or time period being billed.  

  3.4.2 **Payment Terms.** Contoso shall pay all undisputed amounts within **forty-five (45) days** from the date of receipt of invoice (“**Net 45**”). Payment shall be made in U.S. dollars by wire transfer or such other method as the Parties may agree in writing.  

3.5 **Disputed Amounts.**  
If Contoso disputes any portion of an invoice, Contoso shall notify Quantum Labs in writing within fifteen (15) Business Days of receipt, specifying the basis for the dispute. The Parties shall use good faith efforts to resolve the dispute promptly. Contoso shall timely pay the undisputed portion of the invoice, and payment of the disputed portion may be withheld pending resolution.  

3.6 **Late Payment.**  
Any undisputed amount not paid when due shall accrue interest from the due date until paid in full at a rate equal to the lesser of: (a) one percent (1.0%) per month; or (b) the maximum rate permitted by Applicable Law. Interest shall not accrue on any disputed amounts being withheld in good faith. Quantum Labs’ right to charge interest is without prejudice to its other rights and remedies for non-payment, including suspension as described in Section 4.3.4.  

3.7 **Taxes.**  
Unless expressly stated otherwise, Fees are exclusive of all applicable sales, use, value-added, goods and services, or other similar taxes. Contoso shall be responsible for all such taxes (excluding taxes based on Quantum Labs’ net income, property, or employees). If Quantum Labs is required to collect or pay any such taxes, such amounts shall be added to the invoice and paid by Contoso, provided that Quantum Labs furnishes appropriate documentation.  

3.8 **Expenses and Reimbursement.**  
Contoso shall reimburse Quantum Labs for reasonable, pre-approved out-of-pocket expenses incurred in connection with the performance of the Services, such as travel, lodging, and meals, in accordance with Contoso’s then-current travel and expense policies provided to Quantum Labs in advance. Quantum Labs shall provide receipts or other reasonable documentation for all reimbursable expenses.  

3.9 **No Withholding for Setoff.**  
Except for disputed amounts under Section 3.5, Contoso shall not withhold or set off any amounts due under this Agreement against any sums due from Quantum Labs without Quantum Labs’ prior written consent, provided that nothing in this Section shall limit Contoso’s rights to pursue any claims it may have against Quantum Labs.  

---

## ARTICLE IV – TERM AND TERMINATION  

4.1 **Term.**  
The term of this Agreement shall commence on the Effective Date and shall continue in full force and effect until **April 21, 2025** (the “**Expiration Date**”), unless earlier terminated in accordance with this Article IV (the “**Term**”).  

4.2 **Renewal.**  
The Parties may mutually agree in writing to renew or extend this Agreement for one or more additional terms upon mutually agreed terms and conditions, including any revised fees, scope, and service levels. Any such renewal shall be documented in a written amendment or new agreement signed by both Parties.  

4.3 **Termination for Convenience.**  

  4.3.1 **By Contoso.** Contoso may terminate this Agreement, in whole or in part, for convenience and without cause upon at least **thirty (30) days’** prior written notice to Quantum Labs.  

  4.3.2 **By Quantum Labs.** Quantum Labs may terminate this Agreement for convenience upon at least **sixty (60) days’** prior written notice to Contoso.  

  4.3.3 **Effect on SOWs.** Any termination for convenience may specify whether it applies to the Agreement in its entirety or only to particular SOWs.  

  4.3.4 **Suspension for Non-Payment.** Without limiting any other remedies, Quantum Labs may suspend performance of the Services if any undisputed sum remains unpaid more than fifteen (15) days after written notice of late payment, provided that Quantum Labs resumes Services promptly upon receipt of all overdue amounts.  

4.4 **Termination for Cause.**  

  4.4.1 **Material Breach.** Either Party may terminate this Agreement or any SOW immediately upon written notice if the other Party materially breaches this Agreement or such SOW and fails to cure such breach within thirty (30) days (or ten (10) days for non-payment) after receipt of written notice specifying the breach.  

  4.4.2 **Insolvency.** Either Party may terminate this Agreement immediately upon written notice if the other Party: (a) becomes insolvent or unable to pay its debts as they become due; (b) files or has filed against it a petition for bankruptcy or similar relief which is not dismissed within sixty (60) days; or (c) makes an assignment for the benefit of creditors or ceases to carry on business.  

4.5 **Effect of Termination or Expiration.**  

  (a) **Cessation of Services.** Upon termination or expiration of this Agreement, Quantum Labs shall cease performing the Services, except as necessary to effect an orderly wind-down.  

  (b) **Payment of Outstanding Amounts.** Contoso shall pay Quantum Labs for all Services properly performed and reimbursable expenses incurred through the effective date of termination or expiration, and for any agreed transition assistance in accordance with Section 4.6.  

  (c) **Return of Materials.** Each Party shall promptly return or, upon the other Party’s written request, destroy (and certify destruction of) any Confidential Information of the other Party in its possession or control, subject to any rights or obligations under Article XI (Data Protection) and Section 5.4 (Survival).  

  (d) **Survival of Rights.** Any rights and obligations that by their nature should survive termination or expiration (including, without limitation, payment obligations accrued prior to termination, confidentiality, IP ownership, indemnification, limitations of liability, and dispute resolution) shall survive in accordance with Section 16.9.  

4.6 **Transition Assistance.**  
At Contoso’s request made prior to the effective date of termination or expiration, Quantum Labs shall provide reasonable transition assistance to facilitate the orderly transfer of the Services to Contoso or another service provider, for up to ninety (90) days following such date. Such assistance shall be provided at Quantum Labs’ then-current time-and-materials rates, unless termination is due to Quantum Labs’ uncured material breach, in which case reasonable transition assistance (not exceeding forty (40) hours) shall be provided at no additional charge.  

---

## ARTICLE V – CONFIDENTIALITY  

5.1 **Definition of Confidential Information.**  
“**Confidential Information**” means all non-public, proprietary, or confidential information disclosed by or on behalf of a Party (the “**Disclosing Party**”) to the other Party (the “**Receiving Party**”), whether orally or in writing, that is designated as confidential or that a reasonable person would understand to be confidential given the nature of the information and the circumstances of disclosure. Confidential Information includes, without limitation, business plans, strategies, financial information, technical data, product plans, software (including source code and object code), Client Data, Personal Data, and the terms and conditions of this Agreement (including pricing).  

5.2 **Obligations of Confidentiality.**  
The Receiving Party shall:  

  (a) use Confidential Information solely as necessary to perform its obligations or exercise its rights under this Agreement;  

  (b) not disclose Confidential Information to any third party except as expressly permitted herein; and  

  (c) protect Confidential Information using at least the same degree of care that it uses to protect its own similar information, but in no event less than reasonable care.  

5.3 **Permitted Disclosures.**  
The Receiving Party may disclose Confidential Information:  

  (a) to its and its Affiliates’ employees, officers, directors, contractors, and professional advisors who have a “need to know” such information for purposes of this Agreement and who are bound by confidentiality obligations no less stringent than those in this Article V; and  

  (b) to the extent required by Applicable Law or by order of a court or governmental authority, provided that the Receiving Party (to the extent legally permitted) gives the Disclosing Party prompt written notice and cooperates reasonably in any effort to limit or contest such disclosure.  

5.4 **Exclusions.**  
Confidential Information does not include information that the Receiving Party can demonstrate:  

  (a) is or becomes publicly available through no breach of this Agreement by the Receiving Party;  

  (b) was lawfully known to the Receiving Party without restriction prior to disclosure;  

  (c) is received lawfully from a third party without restriction on disclosure; or  

  (d) is independently developed by the Receiving Party without use of or reference to the Disclosing Party’s Confidential Information.  

5.5 **Survival.**  
The obligations in this Article V shall remain in effect for a period of **five (5) years** after expiration or termination of this Agreement; provided, however, that obligations relating to trade secrets and Personal Data shall continue for so long as such information remains a trade secret or Personal Data, respectively, under Applicable Law.  

---

## ARTICLE VI – INTELLECTUAL PROPERTY RIGHTS  

6.1 **Ownership of Work Product.**  
Subject to Sections 6.2 and 6.3, and upon Contoso’s payment in full of all Fees associated with the applicable Deliverables, all right, title, and interest in and to the Work Product (including Deliverables) created specifically for Contoso under this Agreement shall be owned exclusively by Contoso. To the extent any Work Product does not automatically vest in Contoso by operation of law, Quantum Labs hereby assigns and agrees to assign to Contoso all such right, title, and interest, subject to the rights granted to Quantum Labs in Section 6.3.  

6.2 **Client Data and Materials.**  
As between the Parties, Contoso shall retain all right, title, and interest in and to the Client Data and any Contoso-provided materials or intellectual property. Quantum Labs is granted a limited, non-exclusive, non-transferable license during the Term to use such Client Data and materials solely as necessary to perform the Services.  

6.3 **Vendor Pre-Existing IP and Tools.**  
Notwithstanding anything to the contrary, Quantum Labs retains all right, title, and interest in and to any and all pre-existing or independently developed software, algorithms, models, methodologies, tools, libraries, frameworks, and other intellectual property owned or controlled by Quantum Labs prior to the Effective Date or developed independently of this Agreement (“**Vendor Pre-Existing IP**”). To the extent Vendor Pre-Existing IP is incorporated into any Deliverable, Quantum Labs hereby grants to Contoso a worldwide, perpetual, irrevocable, non-exclusive, royalty-free license (with the right to sublicense to Contoso’s Affiliates and service providers solely for Contoso’s internal business purposes) to use, execute, reproduce, display, and modify such Vendor Pre-Existing IP as embedded in or necessary to use the Deliverables.  

6.4 **Third-Party Materials.**  
To the extent any Third-Party Materials are incorporated in or required to use any Deliverable, Quantum Labs shall identify such materials and the applicable license terms in the SOW or Documentation. Contoso’s rights to such Third-Party Materials are subject to the terms of the applicable third-party licenses. Quantum Labs shall not incorporate any Third-Party Materials under terms that are materially inconsistent with this Agreement without Contoso’s prior written consent.  

6.5 **Residuals.**  
Quantum Labs shall be free to use general knowledge, skills, and experience, and any ideas, concepts, know-how, and techniques that are retained in the unaided memory of its personnel after performing the Services, provided that Quantum Labs does not use or disclose Contoso’s Confidential Information or Client Data in violation of this Agreement.  

6.6 **Moral Rights.**  
To the maximum extent permitted by Applicable Law, Quantum Labs hereby waives, and shall cause its personnel and subcontractors to waive, any moral rights in the Work Product in favor of Contoso, insofar as such rights relate to the use, modification, or exploitation of the Work Product by or on behalf of Contoso.  

---

## ARTICLE VII – REPRESENTATIONS AND WARRANTIES  

7.1 **Mutual Representations and Warranties.**  
Each Party represents and warrants that:  

  (a) it is duly organized, validly existing, and in good standing under the laws of its jurisdiction of organization;  

  (b) it has full corporate power and authority to enter into this Agreement and to carry out its obligations hereunder;  

  (c) this Agreement constitutes a legal, valid, and binding obligation of such Party, enforceable in accordance with its terms; and  

  (d) its execution and performance of this Agreement do not conflict with or violate any agreement to which it is a party or any Applicable Law.  

7.2 **Quantum Labs’ Warranties.**  
Quantum Labs further represents and warrants that:  

  (a) the Services shall be performed in a professional and workmanlike manner, in accordance with generally accepted industry standards and Applicable Law;  

  (b) the Deliverables, when used in accordance with the Documentation, will materially conform to the Specifications for a period of ninety (90) days from acceptance (“**Warranty Period**”);  

  (c) to Quantum Labs’ knowledge, the Deliverables and Services, as provided by Quantum Labs, do not infringe any third party’s Intellectual Property Rights; and  

  (d) it shall maintain, during the Term, adequate resources and qualified personnel to perform the Services.  

7.3 **Contoso’s Warranties.**  
Contoso represents and warrants that:  

  (a) it has the right to provide the Client Data and any other materials it provides to Quantum Labs for use in connection with the Services; and  

  (b) the use of Client Data by Quantum Labs in accordance with this Agreement will not infringe or misappropriate any third-party rights or violate Applicable Law, provided that Quantum Labs uses Client Data solely as permitted hereunder.  

7.4 **Remedies for Breach of Warranty.**  
In the event of a breach of the warranties in Section 7.2(b), Contoso’s exclusive remedy and Quantum Labs’ sole obligation shall be, at Quantum Labs’ option and expense: (a) to use commercially reasonable efforts to correct the non-conformity; or (b) if such correction is not commercially reasonable, to refund to Contoso the Fees paid for the non-conforming Deliverable, in which case Contoso shall cease using such Deliverable.  

7.5 **Disclaimer.**  
EXCEPT AS EXPRESSLY PROVIDED IN THIS ARTICLE VII, NEITHER PARTY MAKES ANY OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, OR WARRANTIES ARISING FROM COURSE OF DEALING OR USAGE OF TRADE.  

---

## ARTICLE VIII – INDEMNIFICATION  

8.1 **Indemnification by Quantum Labs.**  
Quantum Labs shall defend, indemnify, and hold harmless Contoso and its Affiliates, and their respective officers, directors, employees, and agents (collectively, “**Contoso Indemnitees**”) from and against any and all third-party claims, demands, suits, actions, damages, losses, liabilities, costs, and expenses (including reasonable attorneys’ fees) (“**Claims**”) arising out of or relating to:  

  (a) any allegation that the Services or Deliverables, as provided by Quantum Labs, infringe or misappropriate any third party’s Intellectual Property Rights;  

  (b) Quantum Labs’ gross negligence or willful misconduct in connection with the performance of the Services; or  

  (c) Quantum Labs’ material breach of this Agreement (including Article XI, Data Protection).  

8.2 **Indemnification by Contoso.**  
Contoso shall defend, indemnify, and hold harmless Quantum Labs and its Affiliates, and their respective officers, directors, employees, and agents (collectively, “**Quantum Labs Indemnitees**”) from and against any Claims arising out of or relating to:  

  (a) any allegation that the Client Data, or Contoso’s direction or instruction regarding the use of the Deliverables, infringes or misappropriates any third party’s rights;  

  (b) Contoso’s gross negligence or willful misconduct; or  

  (c) Contoso’s material breach of this Agreement.  

8.3 **Indemnification Procedure.**  
The Party seeking indemnification (the “**Indemnified Party**”) shall:  

  (a) promptly notify the other Party (the “**Indemnifying Party**”) in writing of any Claim for which indemnification is sought (provided that failure to give prompt notice shall not relieve the Indemnifying Party of its obligations except to the extent materially prejudiced);  

  (b) permit the Indemnifying Party to control the defense and settlement of the Claim, provided that the Indemnifying Party shall not settle any Claim in a manner that imposes any admission of liability or any non-monetary obligation on the Indemnified Party without the Indemnified Party’s prior written consent; and  

  (c) provide reasonable cooperation and assistance to the Indemnifying Party at the Indemnifying Party’s expense.  

8.4 **Infringement Remedies.**  
If any Deliverable or Service becomes, or in Quantum Labs’ reasonable opinion is likely to become, the subject of a Claim of infringement:  

  (a) Quantum Labs may modify or replace the Deliverable or Service so that it is non-infringing while substantially preserving its functionality; or  

  (b) if such modification or replacement is not commercially reasonable, Quantum Labs may terminate the affected Deliverable or Service and refund to Contoso any prepaid, unused Fees for such Deliverable or Service.  

This Section 8.4 sets forth Contoso’s exclusive remedy for intellectual property infringement claims relating to the Deliverables or Services.  

---

## ARTICLE IX – LIMITATION OF LIABILITY  

9.1 **Exclusion of Certain Damages.**  
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER PARTY SHALL BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, EXEMPLARY, OR PUNITIVE DAMAGES (INCLUDING LOSS OF PROFITS, REVENUE, OR GOODWILL) ARISING OUT OF OR RELATING TO THIS AGREEMENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES AND REGARDLESS OF THE THEORY OF LIABILITY.  

9.2 **Cap on Liability.**  
TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, AND SUBJECT TO SECTION 9.3, EACH PARTY’S AGGREGATE LIABILITY ARISING OUT OF OR RELATING TO THIS AGREEMENT (WHETHER IN CONTRACT, TORT, OR OTHERWISE) SHALL NOT EXCEED AN AMOUNT EQUAL TO **THREE (3) TIMES** THE TOTAL FEES PAID OR PAYABLE BY CONTOSO TO QUANTUM LABS UNDER THIS AGREEMENT DURING THE TWELVE (12) MONTHS IMMEDIATELY PRECEDING THE EVENT GIVING RISE TO THE CLAIM.  

9.3 **Exceptions.**  
The limitations in Section 9.2 shall not apply to:  

  (a) a Party’s indemnification obligations under Article VIII;  

  (b) a Party’s breach of its confidentiality obligations under Article V;  

  (c) a Party’s gross negligence or willful misconduct; or  

  (d) Quantum Labs’ liability for data breach caused by its failure to comply with Article XI, to the extent such liability cannot be limited under Applicable Law.  

9.4 **Risk Allocation.**  
The Parties acknowledge that the limitations and exclusions of liability in this Article IX are a fundamental element of the bargain between the Parties and are reflected in the pricing and other terms of this Agreement.  

---

## ARTICLE X – INSURANCE  

10.1 **Required Insurance.**  
During the Term, Quantum Labs shall maintain, at its own expense, insurance coverage with financially sound and reputable insurers, including:  

  (a) **Commercial General Liability** with a limit of not less than US$1,000,000 per occurrence and US$2,000,000 in the aggregate;  

  (b) **Professional Liability / Errors and Omissions** (including technology errors and omissions) with a limit of not less than US$2,000,000 per claim and US$2,000,000 in the aggregate;  

  (c) **Cyber Liability / Data Breach Insurance** covering data security and privacy liability, including regulatory investigations and notification costs, with a limit of not less than US$2,000,000 in the aggregate; and  

  (d) **Workers’ Compensation and Employers’ Liability** as required by Applicable Law in the jurisdictions where Quantum Labs’ employees perform the Services.  

10.2 **Certificates of Insurance.**  
Upon Contoso’s reasonable request, Quantum Labs shall provide certificates of insurance evidencing the required coverages. Quantum Labs shall provide prompt written notice to Contoso of any cancellation or material reduction in coverage.  

10.3 **Primary Coverage.**  
Quantum Labs’ insurance shall be primary to any insurance maintained by Contoso with respect to claims arising from the Services, and such insurance shall not be reduced or invalidated by any act or omission of Contoso.  

---

## ARTICLE XI – DATA PROTECTION AND PRIVACY  

11.1 **Compliance with Data Protection Laws.**  
Each Party shall comply with all Applicable Laws regarding data protection and privacy, including GDPR, CCPA, and any other data protection laws applicable to the processing of Personal Data under this Agreement.  

11.2 **Role of the Parties.**  
For purposes of data protection laws, Contoso is the “controller” (or equivalent term) and Quantum Labs is the “processor” (or equivalent term) with respect to Personal Data contained in Client Data that Quantum Labs processes in the course of providing the Services.  

11.3 **Processing Instructions.**  
Quantum Labs shall process Personal Data solely on documented instructions from Contoso, as set forth in this Agreement, any SOW, and any separate data processing agreement or addendum executed by the Parties, except as otherwise required by Applicable Law.  

11.4 **Security Measures.**  
Quantum Labs shall implement and maintain appropriate technical and organizational measures designed to protect Personal Data against accidental or unlawful destruction, loss, alteration, unauthorized disclosure, or access, consistent with industry standards and Applicable Law.  

11.5 **Data Breach Notification.**  
In the event of a confirmed unauthorized access to or disclosure of Personal Data for which Quantum Labs is responsible under this Agreement (a “**Data Breach**”), Quantum Labs shall:  

  (a) notify Contoso without undue delay and in any event within seventy-two (72) hours after becoming aware of the Data Breach;  

  (b) provide Contoso with sufficient information to meet any reporting or notification obligations under Applicable Law;  

  (c) take appropriate steps to contain, investigate, and remediate the Data Breach; and  

  (d) cooperate reasonably with Contoso regarding any communications with affected individuals or regulators.  

11.6 **Subprocessors.**  
Quantum Labs may engage subprocessors to process Personal Data on its behalf, provided that: (a) each subprocessor is subject to written data protection obligations that are no less protective than those imposed on Quantum Labs under this Agreement; and (b) Quantum Labs remains liable for the acts and omissions of its subprocessors.  

11.7 **Data Subject Rights and Assistance.**  
Quantum Labs shall assist Contoso, to the extent reasonably practicable and at Contoso’s cost (unless such assistance is required due to Quantum Labs’ breach of this Agreement), in responding to data subject requests to exercise rights under Applicable Law (e.g., access, rectification, deletion, portability) and in carrying out data protection impact assessments or consultations with supervisory authorities related to the Services.  

11.8 **Data Retention and Deletion.**  
Quantum Labs shall retain Client Data, including Personal Data, only for as long as necessary to perform the Services or as required by Applicable Law. Upon expiration or termination of this Agreement, or upon Contoso’s written request, Quantum Labs shall promptly delete or return Client Data, at Contoso’s option, except to the extent retention is required by Applicable Law. Any retained Client Data shall remain subject to the confidentiality and security obligations of this Agreement.  

---

## ARTICLE XII – SERVICE LEVEL AGREEMENTS (SLA)  

12.1 **Service Availability.**  
Quantum Labs shall use commercially reasonable efforts to ensure that any production environment hosted or managed by Quantum Labs for Contoso as part of the Services is available at least **99.9%** of the time in each calendar month, excluding scheduled maintenance and excused downtime (a “**Service Level Commitment**”).  

12.2 **Scheduled Maintenance.**  
Quantum Labs may perform scheduled maintenance that may affect service availability, provided that (a) such maintenance is conducted during non-peak hours where reasonably practicable; and (b) Quantum Labs provides at least forty-eight (48) hours’ prior notice via email or the agreed communication channel. Scheduled maintenance shall not count as downtime for purposes of calculating service availability.  

12.3 **Incident Response and Resolution Times.**  
Quantum Labs shall classify incidents based on impact and severity and shall use commercially reasonable efforts to meet the following target response and resolution times:  

  - **Severity 1 (Critical):** System severely impacted or inoperable with no workaround.  
    - Initial response: within 1 hour (24x7).  
    - Target resolution or workaround: within 4 hours.  

  - **Severity 2 (High):** Significant impact or partial loss of functionality; workaround available.  
    - Initial response: within 4 Business Hours.  
    - Target resolution: within 1 Business Day.  

  - **Severity 3 (Medium):** Non-critical issues, minor impact, or general service requests.  
    - Initial response: within 1 Business Day.  
    - Target resolution: within 5 Business Days.  

  - **Severity 4 (Low):** Cosmetic issues or inquiries with negligible impact.  
    - Initial response: within 2 Business Days.  
    - Target resolution: as reasonably practicable.  

12.4 **Service Credits.**  
If Quantum Labs fails to meet the Service Level Commitment for a given calendar month, Contoso may be entitled to service credits as follows (to be applied to future invoices):  

  - Availability ≥ 99.5% but < 99.9%: 3% of the monthly Fees for the affected Services;  
  - Availability ≥ 99.0% but < 99.5%: 5% of the monthly Fees for the affected Services;  
  - Availability < 99.0%: 10% of the monthly Fees for the affected Services.  

Contoso must request service credits in writing within thirty (30) days after the end of the relevant month. Service credits shall be Contoso’s sole and exclusive remedy for failure to meet the Service Level Commitment, without prejudice to any termination rights under Article IV in case of chronic failures.  

12.5 **Exclusions.**  
SLA obligations shall not apply to any downtime or service degradation caused by: (a) Contoso’s or any third party’s systems, networks, or software; (b) misuse or unauthorized use of the Services by Contoso or its users; (c) Force Majeure Events; or (d) scheduled maintenance.  

---

## ARTICLE XIII – CHANGE MANAGEMENT  

13.1 **Change Requests.**  
Either Party may propose changes to the scope, Deliverables, or timelines of the Services by submitting a written change request (“**Change Request**”). Each Change Request shall include a description of the proposed change and the reasons for the change.  

13.2 **Impact Assessment.**  
Upon receipt of a Change Request from Contoso, Quantum Labs shall, within a reasonable period, provide an impact assessment describing: (a) the effect of the change on the scope, schedule, and resource requirements; (b) any adjustments to Fees; and (c) any other anticipated implications.  

13.3 **Approval of Changes.**  
No Change Request shall be binding unless memorialized in a written change order or amendment (“**Change Order**”) signed by authorized representatives of both Parties. Unless and until a Change Order is executed, Quantum Labs shall continue to perform the Services in accordance with the existing scope and SOW.  

13.4 **Urgent Changes.**  
In urgent situations affecting system stability, security, or compliance, Quantum Labs may implement temporary changes without prior written approval, provided that Quantum Labs notifies Contoso as soon as reasonably practicable and documents such changes for subsequent review and approval.  

---

## ARTICLE XIV – DISPUTE RESOLUTION  

14.1 **Negotiation and Escalation.**  
In the event of any dispute, controversy, or claim arising out of or relating to this Agreement (a “**Dispute**”), the Parties shall first seek to resolve the Dispute informally through good faith negotiations between designated representatives. If the Dispute is not resolved within fifteen (15) Business Days, either Party may escalate the Dispute to senior executives of the Parties, who shall attempt to resolve the Dispute within an additional fifteen (15) Business Days.  

14.2 **Mediation.**  
If the Dispute is not resolved through negotiation and escalation as described in Section 14.1, the Parties agree to attempt to resolve the Dispute by non-binding mediation administered by a mutually agreed mediation provider, to be held in New York, New York, unless the Parties agree otherwise. Each Party shall bear its own costs of mediation and share equally in the mediator’s fees.  

14.3 **Arbitration / Litigation.**  
If the Dispute is not resolved by mediation within sixty (60) days of the appointment of a mediator, either Party may pursue its legal remedies. Unless the Parties mutually agree to binding arbitration, any legal action or proceeding shall be brought exclusively in the state or federal courts located in New York County, New York, and each Party hereby submits to the personal jurisdiction and venue of such courts.  

14.4 **Injunctive Relief.**  
Notwithstanding the foregoing, either Party may seek temporary, preliminary, or permanent injunctive relief or other equitable relief at any time from any court of competent jurisdiction to protect its Confidential Information, Intellectual Property Rights, or Personal Data.  

---

## ARTICLE XV – FORCE MAJEURE  

15.1 **Definition.**  
A “**Force Majeure Event**” means any event beyond a Party’s reasonable control, including acts of God, natural disasters, war, terrorism, civil unrest, strikes, labor disputes, pandemics, epidemics, governmental actions, failures or outages of utilities or telecommunications, or other similar causes, provided that such event could not reasonably have been anticipated or mitigated by the affected Party.  

15.2 **Notice and Mitigation.**  
The affected Party shall: (a) promptly notify the other Party in writing of the occurrence of a Force Majeure Event and its expected duration; and (b) use commercially reasonable efforts to mitigate the effects of the Force Majeure Event and resume performance as soon as reasonably practicable.  

15.3 **Suspension and Termination.**  
The obligations of a Party affected by a Force Majeure Event shall be suspended to the extent and for the duration of the Force Majeure Event. If a Force Majeure Event continues for more than thirty (30) consecutive days and materially affects performance of the Services, either Party may terminate the affected SOW or this Agreement, in whole or in part, upon fifteen (15) days’ written notice to the other Party.  

---

## ARTICLE XVI – GENERAL PROVISIONS  

16.1 **Governing Law.**  
This Agreement shall be governed by and construed in accordance with the laws of the State of **New York**, without giving effect to any choice-of-law or conflict-of-law provisions that would result in the application of the laws of any other jurisdiction.  

16.2 **Entire Agreement.**  
This Agreement (including its reference number AGR-QUA-202404-235), together with all SOWs, Change Orders, and any data processing addenda executed by the Parties, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, proposals, negotiations, representations, and understandings, whether written or oral.  

16.3 **Amendments.**  
No amendment or modification of this Agreement shall be valid or binding unless it is in writing and signed by authorized representatives of both Parties. Email exchanges shall not constitute an amendment unless expressly stated and executed via accepted electronic signature methods.  

16.4 **Severability.**  
If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, the remaining provisions shall remain in full force and effect, and the Parties shall negotiate in good faith a substitute provision that most nearly reflects the Parties’ original intent.  

16.5 **Waiver.**  
No waiver of any provision of this Agreement shall be effective unless in writing and signed by the Party against whom the waiver is asserted. No failure or delay by either Party in exercising any right, power, or remedy under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power, or remedy preclude any other or further exercise thereof.  

16.6 **Assignment.**  
Neither Party may assign or transfer this Agreement, in whole or in part, without the prior written consent of the other Party, except that either Party may assign this Agreement without such consent to an Affiliate or to a successor in interest in connection with a merger, acquisition, or sale of substantially all of its assets, provided that the assignee agrees in writing to be bound by this Agreement. Any attempted assignment in violation of this Section shall be null and void.  

16.7 **Independent Contractors.**  
The Parties are independent contractors, and nothing in this Agreement shall be construed to create a partnership, joint venture, agency, or employment relationship between the Parties. Neither Party is authorized to make any representations or commitments on behalf of the other Party unless expressly authorized in writing.  

16.8 **Notices.**  
All notices and other communications required or permitted under this Agreement shall be in writing and shall be deemed given: (a) when delivered personally; (b) when sent by email with confirmation of delivery (provided that a copy is sent by another method described herein); (c) three (3) Business Days after being sent by certified or registered mail, return receipt requested; or (d) one (1) Business Day after being sent by recognized overnight courier, in each case to the addresses set forth below (or to such other address as a Party may designate by notice in accordance with this Section):

**For Contoso (Client):**  
Contoso Enterprises  
Attn: [Title or Department]  
[Street Address]  
[City, State, Zip]  
Email: [Notice Email Address]  

**For Quantum Labs (Vendor):**  
Quantum Labs  
Attn: [Title or Department]  
[Street Address]  
[City, State, Zip]  
Email: [Notice Email Address]  

16.9 **Survival.**  
The following provisions shall survive expiration or termination of this Agreement: Articles III (to the extent of accrued payment obligations), V, VI, VII (to the extent relating to post-termination rights), VIII, IX, X, XI (to the extent required by law), XIV, XVI, and any other provisions which by their nature should survive.  

16.10 **Counterparts; Electronic Signatures.**  
This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Signatures delivered by electronic means (including PDF, DocuSign, or similar) shall be deemed original signatures and fully effective for all purposes.  

---

## SIGNATURES  

IN WITNESS WHEREOF, the Parties hereto have executed this Strategic Partnership and Services Agreement, reference number **AGR-QUA-202404-235**, as of the Effective Date first above written.

### For Contoso Enterprises (Client / Company)

Name of Company: **Contoso Enterprises**  

By: _________________________________  
Name: _______________________________  
Title: ________________________________  
Date: ________________________________  

Witness (if applicable):  
Signature: ____________________________  
Name: _______________________________  
Date: ________________________________  

---

### For Quantum Labs (Vendor / Service Provider)

Name of Company: **Quantum Labs**  

By: _________________________________  
Name: _______________________________  
Title: ________________________________  
Date: ________________________________  

Witness (if applicable):  
Signature: ____________________________  
Name: _______________________________  
Date: ________________________________  

---

*End of Agreement AGR-QUA-202404-235*